Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-17

FDA Approved: RITONAVIR — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original application for Ritonavir, a generic protease inhibitor used in HIV therapy as a pharmacokinetic booster in combin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ritonavir (Ritonavir)

Snippet

ORIG AP for RITONAVIR (RITONAVIR)